Making a pragmatic choice for fluid resuscitation in critically ill patients

JAMA

Volumn 310, Issue 17, 2013, Pages 1803-1804

  Seymour, Christopher W ^a   Angus, Derek C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HETASTARCH; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

BLOOD VOLUME; CRITICALLY ILL PATIENT; EDEMA; EDITORIAL; FLUID RESUSCITATION; HUMAN; HYPOVOLEMIC SHOCK; INFECTION RISK; INTENSIVE CARE UNIT; KIDNEY INJURY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 84887038863     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.280503     Document Type: Editorial

References (20)

1. Jones D, McEvoy S, Merz TM, et al. International albumin use. Anaesth Intensive Care. 2010;38(2):266-273.
2. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243-1251.
3. Rackow EC, Falk JL, Fein IA, et al. Fluid resuscitation in circulatory shock. Crit Care Med. 1983;11(11):839-850.
4. American Thoracic Society. Evidence-based colloid use in the critically ill. Am J Respir Crit Care Med. 2004;170(11):1247-1259.
5. Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med. 2011;3(88):88ps25.
6. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. JAMA. 2013;309(7):678-688.
7. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients. BMJ. 1998;317(7153):235-240.
8. Offringa M. Excess mortality after human albumin administration in critically ill patients. BMJ. 1998;317(7153):223-224.
9. Beale RJ, Wyncoll DL, McLuckie A. Human albumin administration in critically ill patients. BMJ. 1998;317(7162):884.
10. Allison SP, Lobo DN. Debate: albumin administration should not be avoided. Crit Care. 2000;4(3):147-150.
11. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247-2256.
12. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139.
13. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367(2):124-134.
14. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901-1911.
15. Annane D, Siami S, Jaber S; CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. doi:10.1001/jama.2013.280502.
16. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283- 1297.
17. Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357(9):874-884.
18. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.
19. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566- 1572.
20. Meurer WJ, Lewis RJ, Berry DA. Adaptive clinical trials. JAMA. 2012;307(22):2377-2378.